Radiopharm Theranostics (RADX) Debt Ratio (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Debt Ratio for 2 consecutive years, with 0.37 as the latest value for Q2 2025.
- On a quarterly basis, Debt Ratio fell 20.01% to 0.37 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.37, a 20.01% decrease, with the full-year FY2025 number at 0.37, down 20.01% from a year prior.
- Debt Ratio was 0.37 for Q2 2025 at Radiopharm Theranostics, down from 0.46 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.46 in Q2 2024 to a low of 0.37 in Q2 2025.